These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8403574

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM, Mooij JM, Roujouleh H.
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract] [Full Text] [Related]

  • 4. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M, Abad Gosálvez A, Colomina Avilés J, Pascual Pérez R, Ferriz Moreno P.
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A, Salifu MO, Lunde NM, Bansal V, Fishbane S, Dougherty FC, Beyer U, Ba16285 Study Investigators.
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
    Ruedin P, Pechère Bertschi A, Chapuis B, Benedet P, Leski M.
    Nephrol Dial Transplant; 1993 Apr; 8(4):315-8. PubMed ID: 8390005
    [Abstract] [Full Text] [Related]

  • 7. Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequences.
    Grützmacher P, Tsobanelis T, Roth P, Werner E, Vlachojannis J, Kaltwasser J, Kurz P, Scheuermann EH, Schoeppe W.
    Clin Nephrol; 1992 Apr; 38 Suppl 1():S92-7. PubMed ID: 1295714
    [Abstract] [Full Text] [Related]

  • 8. [Use of recombinant erythropoietin on secondary anemia in patients in the terminal phase of renal insufficiency on hemodialysis].
    Gasparović V, Puretić Z, Vrhovac B, Gjurasin M, Puljević D.
    Acta Med Iugosl; 1990 Apr; 44(2):129-35. PubMed ID: 2353593
    [Abstract] [Full Text] [Related]

  • 9. [Effect of recombinant human erythropoietin (rEPO) on angina pectoris in patients with chronic maintenance hemodialysis].
    Imamura Y, Hase H.
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):403-8. PubMed ID: 1875559
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy.
    Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE.
    Arch Intern Med; 1990 Apr; 150(4):863-9. PubMed ID: 2183734
    [Abstract] [Full Text] [Related]

  • 12. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
    Urabe A, Mizoguchi H, Takaku F, Miyazaki T, Yachi A, Niitsu Y, Miura Y, Mutoh Y, Fujioka S, Nomura T.
    Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Study of recombinant human erythropoietin treatment on the anemia of predialysis patients].
    Furukawa A, Numata A, Imagawa A, Kaifu Y, Sumikura T, Miyake H, Obayashi S, Nakazora H, Hirohata M, Miki S.
    Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):693-700. PubMed ID: 1479709
    [Abstract] [Full Text] [Related]

  • 15. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B.
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Erythropoietin safety and efficacy in chronic allograft nephropathy.
    Baltar J, Moran N, Ortega F, Ortega T, Rebollo P, Cofan F, Campistol JM.
    Transplant Proc; 2007 Sep; 39(7):2245-7. PubMed ID: 17889152
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.